Please login to the form below

Not currently logged in
Email:
Password:

Metrics appoints director of pharma development

Promotion for Joseph Cobb at contract development and manufacturing organisation

Joseph Cobb has been named as the director of pharmaceutical development at the US contract development and manufacturing company Metrics.

The appointment is a promotion for Cobb, who has been with North Carolina-based Metrics since 2002, serving most recently as associate director of pharmaceutical development.

In his new role, Cobb will oversee Metrics' work in early-phase solid oral dosage development, as well as the company's potent and cytotoxic drug development services.

These services cover pharmaceutical formulation development; first-time- in-man formulations; and the manufacturing of clinical materials for trials covering phase I to III.

“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics' formulation development capabilities,” said Phil Hodges, president of the company, which operates as a subsidiary of Mayne Pharma.

“With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”

7th February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics